Wishing everyone a happy Easter from the T45 Labs team. Grateful for the work, the people, and the chance to pause before moving forward. #T45Labs #Easter #MedTechInnovation #CardiovascularInnovation
About us
T45 Labs is a Silicon Valley-based medtech incubator and investment platform that builds acquisition-ready cardiovascular companies. We reduce development risk by advancing differentiated technologies through critical clinical and regulatory milestones. T45 Labs follows a best-follower strategy: entering validated markets, refining early concepts, and focusing on outcomes, ease of use, and cost efficiency. Through T45 Fund-I and T45 Fund-II, we partner with physicians and entrepreneurs to build differentiated cardiovascular companies with clear paths to strategic acquisition and attractive investor returns.
- Website
-
www.t45labs.com
External link for T45 Labs
- Industry
- Medical Equipment Manufacturing
- Company size
- 11-50 employees
- Headquarters
- Santa Clara
- Type
- Privately Held
- Founded
- 2022
Locations
-
Primary
Get directions
Santa Clara, Headquarters, US
Employees at T45 Labs
Updates
-
Advanced NanoTherapies, Inc part of the T45 Labs development portfolio, is growing its manufacturing team. The company is seeking a Manufacturing Operator in Cleveland, Ohio, to support production activities and continued technology development. Role details: https://lnkd.in/eqHz-ZXV #T45Labs #MedTech #Biotech #Manufacturing #Hiring
Advanced NanoTherapies, Inc continues to expand its manufacturing operations. We are looking for a Manufacturing Operator to join our team onsite in Cleveland, Ohio, supporting the consistent production of our technologies. This is an opportunity to contribute directly to advancing next-generation medical devices in a collaborative, hands-on environment. Full role details: https://lnkd.in/eqHz-ZXV #MedTech #Biotech #Careers #HiringNow #AdvancedNanoTherapies #MedicalDevices
-
-
International Women’s Day highlights both progress and perspective. In cardiovascular health, women’s symptoms have not always fit traditional definitions, shaping how conditions were studied and understood. Equity begins long before a product reaches a patient. It starts with how research is designed and how unmet needs are defined. At T45 Labs, that philosophy guides the cardiovascular companies we build and support, grounded in the belief that intentional innovation creates a stronger future for all. #InternationalWomensDay #IWD2026 #HealthEquity #WomenInMedTech #CardiovascularInnovation
-
-
A T45 Labs portfolio company featured in Cardiovascular Business, highlighting early experience with the A-FLUX® coronary sinus reducer. Continued disciplined development underway. #CardiovascularInnovation #MedTech #ClinicalDevelopment #T45Labs
The self-expanding, recapturable coronary sinus reducer from VahatiCor Inc was associated with a safe implant procedure and "promising" clinical outcomes. Additional research is already underway.
-
What does it take to move a cardiovascular concept to clinical and commercial reality? On Powering the Future Within, Marwan Berrada-Sounni, Founder and Managing Partner of T45 Labs, shares how T45 builds companies through a best-follower strategy. The approach pairs deep clinical insight with disciplined execution, a focus on meaningful differentiation, and early attention to workflow, manufacturability, and margin discipline as design decisions rather than afterthoughts. In this clip, Marwan explains how studying emerging technologies, identifying where clinical gaps remain, and committing only when the foundation is strong shape T45's approach. Full episode link in the comments. #MedTech #Cardiovascular #MedicalDevices #HealthInnovation #StartupBuilding #Commercialization #ProductDevelopment #ClinicalInnovation
-
National Heart Month is a reminder of the scale and complexity of cardiovascular disease, and the continued need for innovation. Progress in heart health depends on scientific rigor, disciplined development, and collaboration across clinicians, engineers, and investors. At T45 Labs, we build and advance cardiovascular companies focused on addressing significant unmet needs across the spectrum of heart disease. We are proud to support the ongoing advancement of technologies designed to expand understanding and contribute to the future of cardiovascular care. #NationalHeartMonth #CardiovascularInnovation #MedTech #HeartHealth
-
-
Proud to see NuevoSono, a T45 Labs portfolio company, partner with SUPERWISE® to integrate trusted AI into next-generation UltraHD IVUS (UHD IVUS) imaging. This collaboration reflects the kind of disciplined, clinically grounded innovation we support at T45 Labs, combining strong technology foundations with responsible deployment as companies move toward real-world clinical use. #UltraHDIVUS #UHDIVUS #IVUS #CardiovascularInnovation #MedTech #AIinHealthcare #ResponsibleAI #ClinicalInnovation #T45Labs
What turns an AI pilot into real‑world, production‑ready AI? Not the model. The governance. SUPERWISE® is partnering with NuevoSono to bring enterprise‑grade AI governance to their breakthrough IVUS platform, one of the most advanced coronary imaging systems in development. And while this is a healthcare example, the lesson is universal: High‑stakes AI in any industry needs: • Continuous performance monitoring • Explainability for audits • Security and data protections • Guardrails that keep models aligned with outcomes That’s why NuevoSono chose SUPERWISE, to deploy AI responsibly, with transparency and control built in from day one. Trusted AI isn’t optional anymore. It’s the standard. 🔗 Full announcement here: https://lnkd.in/gpUubyvY #AIGovernance #EnterpriseAI #ResponsibleAI #AIInProduction #HealthcareAI
-
-
Coronary microvascular dysfunction (CMD) is one of the most overlooked gaps in cardiovascular care. At T45 Labs, we support teams willing to do the hard, methodical work needed to turn uncertainty into evidence. The research highlighted in Marwan Berrada-Sounni’s article reflects that seriousness. This is how change starts. https://lnkd.in/dqetPhq5 #coronarymicrovasculardysfunction #microishuge #vahaticor #medtech #interventionalcardiology
-
As we enter 2026, we remain focused on advancing the next generation of cardiovascular technologies and supporting the founders and teams working to deliver meaningful solutions for patients. Thank you to everyone who contributes to our progress. 2026 will be just another awesome year! Wishing you a bright and productive start to the new year. #HappyNewYear #Medtech #HealthcareInnovation #T45Labs #team #cardiology #cardiovascular #NewYear2026
-
-
The holiday season reminds us that progress comes from moments of alignment where dedicated people bring focus, discipline, and creativity to the problems that matter. At T45 Labs, we are grateful for the clinicians who push boundaries, the engineers who turn ideas into working prototypes, the investors who believe in thoughtful innovation, and the teams who show up each day committed to advancing cardiovascular care. Thank you for your contributions to our work this year. Wishing you a peaceful and joyful holiday season. #HappyHolidays #Medtech #HealthcareInnovation #T45Labs #team #cardiology #cardiovascular #YearInReview
-